Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) is a growing population health concern. This webinar is a discussion for formulary decision makers that addresses the CKD in T2D landscape and patient journey, offers a clinical overview of an investigational new drug and includes the results from the phase 3 clinical study FIDELIO-DKD.


  • Dr. Eugene E. Wright, Jr, MD
  • Dr. Dan Wilson, MD
  • Kate Peters

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a payer with FormularyDecisions.

Click here for additional information and registration details.


Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.